Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Research Support, N.I.H., Extramural

Randomized Controlled Trial

Clinical Trial, Phase III

Multicenter Study

Publication Year

From

Quick links

Individual year

2024

2017

2016

2014

2010

2009

2006

2003

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Receptors, Corticotropin-Releasing Hormone""[mesh_terms]

14 Results

Searching titles within these results

Update on the role of ovarian corticotropin-releasing hormone.

Erasmia Kiapekou, Evangelia Zapanti, George Mastorakos, Dimitris Loutradis

Annals of the New York Academy of Sciences 2010;1205():225-9

Full Text

Abstract

CRH-like peptides in human reproduction.

E Zoumakis, S N Kalantaridou, A Makrigiannakis

Current medicinal chemistry 2010;16(32):4230-5

Full Text

Abstract

Thiazolo[4,5-d]pyrimidines as a privileged scaffold in drug discovery.

Hesham Fahmy, Bhimanna Kuppast

European journal of medicinal chemistry 2016;113():198-213

Full Text

Abstract

The prevention of preterm labour -- corticotropin releasing hormone type 1 receptors as a target for drug design and development.

S Westcott, J Morgan, K Kirkwood, P A Keller, A McCluskey

Mini reviews in medicinal chemistry 2003;3(4):295-303

Full Text

Abstract

Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1.

Supriyo Bhattacharya, Govindan Subramanian, Spencer Hall, Jianping Lin, Abdelazize Laoui, Nagarajan Vaidehi

Journal of computer-aided molecular design 2010;24(8):659-74

Full Text

Abstract

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.

Henrik Falhammar, Robert H Farber, Eiry Roberts, Julia Sturgeon, Umasuthan Srirangalingam, Gianni Russo, Irina Bancos, Gordon B Cutler, Richard J Auchus, Rosario Pivonello, Florian W Kiefer, Kyriakie Sarafoglou, Patrice Rodien, Andrea M Isidori, Nicole Reisch, Deborah P Merke, Vivian H Lin, Jean L Chan, Oksana Hamidi, Selma F Witchel

The New England journal of medicine 2024;391(6):504-514

Free Full Text

Abstract

Effect of the CRF-receptor antagonist pexacerfont on stress-induced eating and food craving.

David H Epstein, Kenzie L Preston, Karran A Phillips, Yavin Shaham, Markus Heilig, Melody Furnari, Ashley P Kennedy

Psychopharmacology 2017;233(23-24):3921-3932

Free Full Text

Abstract

Structural-functional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonism.

Katerina Spyridaki, Minos-Timotheos Matsoukas, Arnau Cordomi, Kostas Gkountelias, Maria Papadokostaki, Thomas Mavromoustakos, Diomedes E Logothetis, Andrew N Margioris, Leonardo Pardo, George Liapakis

The Journal of biological chemistry 2014;289(27):18966-77

Free Full Text

Abstract

Corticotropin releasing hormone and the skin.

Andrzej Slominski, Blazej Zbytek, Michal Zmijewski, Radomir M Slominski, Sobia Kauser, Jacobo Wortsman, Desmond J Tobin

Frontiers in bioscience : a journal and virtual library 2006;11():2230-48

Free Full Text

Abstract

Corticotropin-releasing factor (CRF) rapidly suppresses apoptosis by acting upstream of the activation of caspases.

Cathrin Hippel, Joachim Spiess, Marko Radulovic

Journal of neurochemistry 2003;84(5):1074-85

Full Text

Abstract

The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27(Kip1) protein up-regulation and c-Myc mRNA down-regulation.

Pierluigi Navarra, Alessandro Sgambato, Cinzia Dello Russo, Alma Boninsegna, Lucia Lisi, Carlo Cenciarelli, Emilia Cantalupo, Maria Laura De Simone, Giacomo Pozzoli

Molecular and cellular endocrinology 2016;412():205-15

Full Text

Abstract